TP53 and colorectal carcinoma: Since p53 and NAD are both proved to influence the energy metabolism in cancer cells and the acetylation of p53 is regulated by NAD-dependent SIRT1 deacetylase [9, 25], the NAD metabolism may be potentially linked with p53 function in CRC tissues.